These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19430287)

  • 1. The article by Fintak et al on the incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    El-Ashry MF; Dhillon B
    Retina; 2009 May; 29(5):720-1; author reply 721-2. PubMed ID: 19430287
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
    Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. We congratulate the authors for publishing their data on bilateral consecutive intravitreal injections administered in their office.
    Shah GY; Ambatipudi S; Fernandes M; Lakshmipathy M; Varma PV; Sachdeva V; Pathengay A
    Retina; 2010 Sep; 30(8):1325-6; author reply 1326-7. PubMed ID: 20827150
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
    Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
    Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
    Bhavsar AR; Googe JM; Stockdale CR; Bressler NM; Brucker AJ; Elman MJ; Glassman AR;
    Arch Ophthalmol; 2009 Dec; 127(12):1581-3. PubMed ID: 20008710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
    Matthews JL; Dubovy SR; Goldberg RA; Flynn HW
    Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
    Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
    Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
    Goldberg RA; Flynn HW; Isom RF; Miller D; Gonzalez S
    Am J Ophthalmol; 2012 Feb; 153(2):204-208.e1. PubMed ID: 22264943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
    Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS
    Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
    Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
    Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
    Chen E; Lin MY; Cox J; Brown DM
    Retina; 2011 Sep; 31(8):1525-33. PubMed ID: 21878800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.
    Goldberg RA; Flynn HW; Miller D; Gonzalez S; Isom RF
    Ophthalmology; 2013 Jul; 120(7):1448-53. PubMed ID: 23453511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.
    Inman ZD; Anderson NG
    Retina; 2011 Apr; 31(4):669-72. PubMed ID: 21178659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
    Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
    Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
    Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endophthalmitis after penetrating ocular injury in the dentist's chair.
    Adam MK; Rahimy E; Brady CJ; Aronsky M; Hsu J; Spirn M
    Can J Ophthalmol; 2014 Dec; 49(6):e154-6. PubMed ID: 25433754
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
    McCannel CA
    Retina; 2011 Apr; 31(4):654-61. PubMed ID: 21330939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
    Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A
    Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
    Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
    Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.